We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Btg Plc | LSE:BTG | London | Ordinary Share | GB0001001592 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 840.00 | 839.00 | 840.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/8/2018 14:43 | Louise should go though , her control and judgement has been in question for over 3 years now. | bargainbob | |
09/8/2018 11:52 | One large seller early doors with 53k shares sold.The rest is small volume day traders taking advantage of the update to push the price down.Time for some good moves with the cash and agreed loan facilities to re-ignite the excitement behind the strategy for the company.A well planned pr effort as soon as the holiday season is over to get the good news message out with key investors and potential investors wouldn't come amiss.Oh! And an early message about success with Varithena at the large clinics through some positive messages from satisfied customers.Last but by no means least, a clear set of market actions as soon as Crofab's competitor hits the market, the battle for market share for the stock build up for the 2019 biting season.Gold old marketing as taught in all the busines schools!I'm close to wiping out any gains I have made since investing in Protherics and that isn't a good feeling! | fhmktg | |
09/8/2018 11:10 | I am guessing Pneumerx will be completely written off, this will likely have real significant costs. No profits this year! | cockneytrader | |
09/8/2018 07:58 | Always the last to know after nothing ever happens spyder. The needle returns to the start of the song and we continue as before. | bargainbob | |
09/8/2018 07:53 | How much will it cost to unwind this? Risk no.1 out of the way and potentially three to go. | cockneytrader | |
08/8/2018 17:29 | Somewhere over the rainbow? | semper vigilans | |
08/8/2018 17:18 | Song titles? Found the following ... “Nothing Ever Happens” “Always The Last To Know” “Kiss This Thing Goodby” “Be My Downfall” Which is it bob? ;-) | spyder | |
08/8/2018 15:51 | Del Amitri | bargainbob | |
06/8/2018 08:21 | Anyone seen any updates on the bid rumour ? | bargainbob | |
30/7/2018 13:17 | certaintly does , just need to get the market round to the good news and let the bad news drift away one by one . Still thinks there more to the bid story . | cannyshoveyergrannyoffthebus | |
30/7/2018 10:53 | From III BTG plc (LSE: BTG), the global healthcare company, highlighted the publication of OPTALYSE PE trial results in JACC: Cardiovascular Interventions. The published findings further confirm that bilateral pulmonary embolism (PE) treated in as little as 2 hours with EKOSⓇ Acoustic Pulse Thrombolysis™ therapy shows significant improvement in RV/LV ratio and with a very low one-year mortality rate of 2% and an equally low one-year recurrent PE rate of 2%. This is with considerably less tissue plasminogen activator (tPA) than used in previous studies1, as low as 8mg total. Looks like a result. | a1ord53 | |
29/7/2018 17:59 | Good post spyder. On the Crofab point Louise talks about transparent market sensitive strategies, do any of you know if it possible to prolong the shelf life of the product ? Because I see as a major week point versus the expected competition. | dp1umb | |
29/7/2018 14:18 | Thanks Spyder . | bargainbob | |
27/7/2018 15:53 | A week that looked like it was going to promise so much ends so flat . Not even a rebuff on the rumour from the company . Strange . | bargainbob | |
26/7/2018 12:31 | It even hard to think who would be interested , though one small part of this business could be the jewal in the crown for someone else to grow . I would not discount a bid at anytime . | cannyshoveyergrannyoffthebus | |
26/7/2018 12:14 | With reporting now in usd, interest in the US May grow.As the next couple of years develop and the issues aroundV, Crofab and licensing come clear, then the I/M and I/O segments will have a logic to a 'sum of the parts' calculation for a hedge fund break up specialist.Hopefully we will be back in the £8-10 range by then. | fhmktg | |
26/7/2018 11:51 | FT Alphaville commenting yesterday on BTG bid rumours thought the company was a bit of a ragbag of interests and so no immediate predators sprang to mind.So no way out there for the long suffering faithful there perhaps :)! | steeplejack | |
25/7/2018 17:11 | To be fair lots of rumours that came to nought over the years . Phillips was another odd tie up mentioned to Btg. One Japanese company also . I wonder if Louise realises how unsupportive of BTG the shareholders both small and large currently are . Certaintly if someone went hostile she would find it hard to fend off. Not that she would be too worried with her free ride. | bargainbob | |
25/7/2018 15:31 | Probably around the time the sepsis trials failed. | dp1umb | |
25/7/2018 14:07 | The last company that reviewed BTG back in 2014 . | cannyshoveyergrannyoffthebus | |
25/7/2018 12:52 | Canny ????? | dp1umb | |
25/7/2018 12:02 | AstraZeneca | cannyshoveyergrannyoffthebus | |
25/7/2018 09:21 | Good post again spyder but you may be wrong about timing, you see back in 2011 axis shield were taken out in a hostile bid from the US and there 1 first move was in the first week of August!! | dp1umb | |
25/7/2018 09:01 | yeah looks likea false start . Still the slender chance it starts again at 2pm. | cannyshoveyergrannyoffthebus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions